Effects of broad-spectrum antibiotics on the colonisation of probiotic yeast Saccharomyces boulardii in the murine gastrointestinal tract.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
25 05 2022
25 05 2022
Historique:
received:
14
01
2022
accepted:
19
04
2022
entrez:
25
5
2022
pubmed:
26
5
2022
medline:
28
5
2022
Statut:
epublish
Résumé
Mouse models are commonly used to study the colonisation profiles of microorganisms introduced to the gastrointestinal tract. Three commonly used mouse models include conventional, germ-free, and antibiotic-treated mice. However, colonisation resistance in conventional mice and specialised equipment for germ-free mice are usually limiting factors in their applications. In this study, we sought to establish a robust colonisation model for Saccharomyces boulardii, a probiotic yeast that has caught attention in the field of probiotics and advanced microbiome therapeutics. We characterised the colonisation of S. boulardii in conventional mice and mice treated with a cocktail of broad-spectrum antibiotics, including ampicillin, kanamycin, metronidazole and vancomycin. We found colonisation levels increased up to 10,000-fold in the antibiotic-treated mice compared to nonantibiotic-treated mice. Furthermore, S. boulardii was detected continuously in more than 75% of mice for 10 days after the last administration in antibiotic-treated mice, in contrast to in nonantibiotic-treated mice where S. boulardii was undetectable in less than 2 days. Finally, we demonstrated that this antibiotic cocktail can be used in two commonly used mouse strains, C57BL/6 and ob/ob mice, both achieving ~ 10
Identifiants
pubmed: 35614092
doi: 10.1038/s41598-022-12806-0
pii: 10.1038/s41598-022-12806-0
pmc: PMC9133042
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
8862Subventions
Organisme : Marie Curie
ID : No 813781
Pays : United Kingdom
Informations de copyright
© 2022. The Author(s).
Références
BMC Microbiol. 2020 Nov 11;20(1):340
pubmed: 33176677
PLoS One. 2014 Nov 12;9(11):e112660
pubmed: 25391025
Nat Biotechnol. 2018 Oct;36(9):857-864
pubmed: 30102294
J Clin Pharmacol. 2018 Oct;58 Suppl 10:S164-S179
pubmed: 30248200
Infect Immun. 2009 Jul;77(7):2741-53
pubmed: 19380465
Front Cell Neurosci. 2021 Jul 15;15:698172
pubmed: 34335190
Therap Adv Gastroenterol. 2013 Jul;6(4):295-308
pubmed: 23814609
Diabetes. 2015 May;64(5):1794-803
pubmed: 25626737
Nature. 2012 Jun 13;486(7402):207-14
pubmed: 22699609
J Mol Med (Berl). 2020 Dec;98(12):1675-1687
pubmed: 33025105
Biopharm Drug Dispos. 1989 Jul-Aug;10(4):353-64
pubmed: 2758101
Adv Drug Deliv Rev. 2016 Oct 1;105(Pt A):44-54
pubmed: 27158095
Genome Med. 2018 Jan 29;10(1):6
pubmed: 29378630
Gastroenterology. 1993 Apr;104(4):1108-15
pubmed: 8462799
Sci Rep. 2017 Mar 23;7(1):371
pubmed: 28336969
Mol Ecol. 2010 Dec;19(24):5555-65
pubmed: 21050295
J Clin Invest. 2012 May;122(5):1717-25
pubmed: 22484814
Therap Adv Gastroenterol. 2012 Mar;5(2):111-25
pubmed: 22423260
Cell. 2015 Dec 3;163(6):1428-43
pubmed: 26638072
Appl Environ Microbiol. 2016 Apr 04;82(8):2280-2287
pubmed: 26850302
Pharm Res. 2014 Dec;31(12):3404-14
pubmed: 24928365
ACS Synth Biol. 2021 May 21;10(5):1039-1052
pubmed: 33843197
Front Microbiol. 2018 Aug 07;9:1619
pubmed: 30131772
Front Neurosci. 2011 Feb 23;5:10
pubmed: 21390289
PLoS One. 2016 Apr 11;11(4):e0153351
pubmed: 27064405
J Adv Vet Anim Res. 2019 Dec 14;7(1):103-114
pubmed: 32219116
Sci Transl Med. 2019 Jan 16;11(475):
pubmed: 30651324
EcoSal Plus. 2004 Dec;1(1):
pubmed: 26443354
Front Microbiol. 2018 Apr 13;9:723
pubmed: 29706942
Methods Mol Biol. 2006;313:107-20
pubmed: 16118429
Lab Anim (NY). 2021 Jul;50(7):185-195
pubmed: 34127866
Sci Rep. 2019 Jan 23;9(1):420
pubmed: 30674978
Infect Immun. 1996 Dec;64(12):5225-32
pubmed: 8945570
Lab Anim (NY). 2017 Mar 22;46(4):114-122
pubmed: 28328896
Front Physiol. 2018 Oct 31;9:1534
pubmed: 30429801
Sci Rep. 2021 Feb 2;11(1):2738
pubmed: 33531650
Microbiome. 2020 Mar 5;8(1):28
pubmed: 32138779
Cell Mol Immunol. 2016 Mar;13(2):251-62
pubmed: 25942514
mBio. 2014 Jun 10;5(3):e01011-14
pubmed: 24917595
Appl Environ Microbiol. 2007 Apr;73(8):2458-67
pubmed: 17293506
Trends Cancer. 2020 Mar;6(3):192-204
pubmed: 32101723
Microbiome. 2020 Sep 12;8(1):133
pubmed: 32919472
Lab Anim Res. 2017 Jun;33(2):119-123
pubmed: 28747977
Int J Obes Suppl. 2019 Apr;9(1):10-19
pubmed: 31391921
Nat Microbiol. 2017 Apr 25;2:17057
pubmed: 28440276
Front Behav Neurosci. 2010 Jun 14;4:29
pubmed: 20676234
Can J Microbiol. 2004 Aug;50(8):615-21
pubmed: 15467787
Biotechniques. 2011 May;50(5):325-8
pubmed: 21548894
PLoS Biol. 2016 Aug 19;14(8):e1002533
pubmed: 27541692
Inflamm Bowel Dis. 2013 Jan;19(1):185-93
pubmed: 22570250
Diabetes. 2014 Aug;63(8):2876-87
pubmed: 24677716
J Hered. 1950 Dec;41(12):317-8
pubmed: 14824537
Therap Adv Gastroenterol. 2020 Jul 29;13:1756284820934315
pubmed: 32774464
Sci Transl Med. 2020 Oct 28;12(567):
pubmed: 33115949
Nucleic Acids Res. 2001 Jan 1;29(1):181-4
pubmed: 11125085
PLoS Biol. 2020 Jul 14;18(7):e3000411
pubmed: 32663221
World J Gastroenterol. 2010 May 14;16(18):2202-22
pubmed: 20458757
Gastroenterology. 2006 Dec;131(6):1812-25
pubmed: 17087945
Aliment Pharmacol Ther. 2017 Aug;46(3):213-224
pubmed: 28612983
FEMS Microbiol Rev. 2016 Jan;40(1):117-32
pubmed: 26323480
Trends Biotechnol. 2019 Jan;37(1):100-115
pubmed: 30318171
Nat Methods. 2009 May;6(5):343-5
pubmed: 19363495
Infect Immun. 2015 May;83(5):1983-91
pubmed: 25733524